The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to antidepressants about unproven pregnancy risks,

March 5 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making it the third drug cleared under the agency's new speedy review program.

Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule.

March 4 () - PepGen said on Wednesday that the U. Food and Drug Administration has placed ‌a partial clinical hold on its mid‑stage trial of ‌a rare muscle disease drug, sending its shares plunging over 25% ​in extended trading.

In a highly unusual move for a normally buttoned-up regulatory agency, a senior official with the US Food and Drug Administration held a call with reporters Thursday to defend the agency’s recent decision on an experimental medicine,

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading claims about compounded versions of popular GLP-1 weight‑loss drugs,

A federal judge questioned Tuesday whether demand for abortion medication would go away even if he were to force the Trump administration to end the policy that allows the drugs to be

2025 brought significant, fast-moving change to the U.S. Food and Drug Administration (FDA), and the organization has undergone extensive modifications as one component of President Donald Trump's efforts to reshape federal healthcare agencies. Regulated ...

The FDA has issued 30 warning letters to telehealth companies over misleading claims about compounded GLP-1 drugs. Regulators say some companies im